---
title: "Aprameya Engineering Ltd (APRAMEYA) — Share Price, Financials & Analysis"
symbol: "APRAMEYA"
company: "Aprameya Engineering Ltd"
canonical: "https://tapetide.com/stocks/APRAMEYA"
isin: "INE0LQG01010"
nse_symbol: "APRAMEYA"
sector: "Healthcare"
industry: "Medical Equipment"
market_cap_cr: 232.29
generated_at: "2026-09-13T18:19:52.250Z"
---

# Aprameya Engineering Ltd (APRAMEYA)

Canonical page: https://tapetide.com/stocks/APRAMEYA

## Company

- **NSE Symbol:** APRAMEYA
- **ISIN:** INE0LQG01010
- **Sector:** Healthcare
- **Industry:** Medical Equipment
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2024-08-01
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** aelhealth.com

## About

Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers.[1]

## Latest Price

- **Price:** ₹116
- **Change:** -4.85 (-4.01%)
- **Open:** ₹122
- **Day High:** ₹122
- **Day Low:** ₹116
- **Previous Close:** ₹120.85
- **Volume:** 24000
- **As Of:** 2026-09-11T09:42:24+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:09.011909Z.

- **Market Cap:** ₹232.29 Cr
- **Classification:** SME
- **P/E (reported):** 44.9
- **Book Value:** ₹36.45
- **Price to Book:** 3.32
- **Dividend Yield:** 0%
- **ROE:** 7.37%
- **ROCE:** 15.23%
- **Debt to Equity:** 0.1
- **Revenue (yearly):** ₹55.6 Cr
- **Net Income:** ₹5.1 Cr
- **EBITDA:** ₹11 Cr
- **52-Week High:** ₹360
- **52-Week Low:** ₹102.1
- **RSI (14):** 44.74

## Tapetide Score

- **Score:** 52 / 100
- **Score date:** 2026-09-04
- **Archetype:** Losing Momentum
- **What it means:** A capable business whose price trend has turned while the multiple is still demanding. Often a re-rating in progress rather than a broken company — watch whether earnings stay resilient.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Falling
- **Percentile:** 56.6 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 76%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 78.89 | 9% |
| growth | 1.62 | 9% |
| momentum | 3.49 | 12% |
| ownership | 63.97 | 24% |
| quality | 93.9 | 22% |
| valuation | 36.62 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has high debtors of 368 days.
- Company's cost of borrowing seems high
- Working capital days have increased from 232 days to 377 days

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 393.52% | -88.44% | 301.74% |
| ebitda margin growth | 8.07% | — | — |
| net income growth | -68.32% | -3% | 42% |
| revenue growth | -59.21% | -11% | 16% |
| roce | -56.86% | — | — |
| roe | -70.61% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Sales | 9.27 | 126.43 | 42.14 | 12.61 |
| Expenses | 10.65 | 100.65 | 31.12 | 13.21 |
| Operating Profit | -1.38 | 25.78 | 11.02 | -0.6 |
| OPM % | -14.89 | 20.39 | 26.15 | -4.76 |
| Other Income | 0.28 | 0.31 | 0.19 | 0.29 |
| Interest | 1.15 | 2.03 | 2.03 | 1.61 |
| Depreciation | 0.05 | 0.05 | 0.05 | 0.05 |
| Profit before tax | -2.3 | 24.01 | 9.13 | -1.97 |
| Tax % | -24.78 | 25.7 | 25.96 | -12.18 |
| Net Profit | -1.73 | 17.84 | 6.76 | -1.72 |
| EPS in Rs | -0.91 | 9.37 | 3.55 | -0.9 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 12.23 | 25.93 | 35 | 78.12 | 65.16 | 135.71 | 54.75 |
| Expenses | 10.64 | 23.52 | 24.95 | 68.67 | 58.81 | 111.31 | 44.34 |
| Operating Profit | 1.59 | 2.41 | 10.05 | 9.45 | 6.35 | 24.4 | 10.41 |
| OPM % | 13 | 9.29 | 28.71 | 12.1 | 9.75 | 17.98 | 19.01 |
| Other Income | 0.09 | 0.08 | 0.04 | 0.21 | 0.46 | 0.59 | 0.49 |
| Interest | 0.9 | 0.87 | 0.14 | 2.08 | 2.11 | 3.18 | 3.64 |
| Depreciation | 0.07 | 0.09 | 0.02 | 0.08 | 0.09 | 0.09 | 0.09 |
| Profit before tax | 0.71 | 1.53 | 9.93 | 7.5 | 4.61 | 21.72 | 7.17 |
| Tax % | 8.45 | 43.79 | 24.87 | 27.33 | 24.3 | 25.78 | 29.71 |
| Net Profit | 0.65 | 0.86 | 7.46 | 5.45 | 3.49 | 16.12 | 5.04 |
| EPS in Rs | — | — | 10.66 | 3.89 | 2.49 | 8.47 | 2.65 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 3.74 | 4.34 | 7 | 14 | 14 | 19.04 | 19.04 |
| Reserves | 0 | 0 | 7.45 | 5.93 | 9.4 | 45.22 | 50.3 |
| Borrowings | 4.03 | 1.48 | 13.69 | 28.74 | 42.05 | 30.34 | 7.12 |
| Other Liabilities | 6.21 | 5.09 | 20.49 | 13.21 | 10.19 | 49.36 | 5.4 |
| Total Liabilities | 13.98 | 10.91 | 48.63 | 61.88 | 75.64 | 143.96 | 81.86 |
| Fixed Assets | 0.69 | 0.63 | 1.54 | 1.49 | 1.43 | 1.38 | 1.39 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0.35 |
| Other Assets | 13.29 | 10.28 | 47.09 | 60.39 | 74.21 | 142.58 | 80.12 |
| Total Assets | 13.98 | 10.91 | 48.63 | 61.88 | 75.64 | 143.96 | 81.86 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0.06 | 3.58 | 10.41 | -13.49 | -9.97 | -10.64 | 31.48 |
| Cash from Investing Activity | -0.57 | 0.03 | -0.24 | -1.83 | -1 | -0.41 | -4.01 |
| Cash from Financing Activity | 0.54 | -3.67 | -7.69 | 13.04 | 11.11 | 10.89 | -27.65 |
| Net Cash Flow | 0.04 | -0.06 | 2.48 | -2.28 | 0.14 | -0.16 | -0.18 |
| Free Cash Flow | -0.31 | 3.55 | 10.38 | -13.52 | -10.58 | -10.89 | 31.31 |
| CFO/OP | 22 | 173 | 149 | -115 | -133 | -28 | 333 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 182.35 | 57.99 | 278.23 | 195.3 | 325.23 | 320.38 | 367.87 |
| Inventory Days | 245.38 | 121.9 | 454.87 | 375.97 | 73.78 | — | 81.04 |
| Days Payable | 268.89 | 146.76 | 1099.89 | 414.62 | 145.83 | — | 95.38 |
| Cash Conversion Cycle | 158.84 | 33.13 | -366.78 | 156.66 | 253.19 | 320.38 | 353.53 |
| Working Capital Days | 39.69 | 36.32 | 199.92 | 116.43 | 152.76 | 165.6 | 377.4 |
| ROCE % | — | 35.32 | 59.31 | 24.94 | 11.78 | 31.12 | 12.64 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2022 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 100% | 73.53% | 73.53% | 73.53% | 74.05% |
| FIIs | 0% | 2.47% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0.7% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 0% | 15.64% | 20.81% | 21.73% | 21.07% |
| Others | 0% | 8.36% | 5.66% | 4.74% | 4.17% |
| No. of Shareholders | 7 | 749 | 628 | 822 | 933 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 5 / 13

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 117.28 | Sell |
| EMA (10) | 117.93 | Sell |
| SMA (20) | 124.13 | Sell |
| EMA (20) | 123.72 | Sell |
| SMA (50) | 138.22 | Sell |
| EMA (50) | 138.02 | Sell |
| SMA (100) | 163.18 | Sell |
| EMA (100) | 159.79 | Sell |
| SMA (200) | 213.72 | Sell |
| EMA (200) | 179.79 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 41.82 | Neutral |
| MACD (12,26,9) | -7.68 | Sell |
| Stochastic (14,3,3) | 37.06 | Neutral |
| ADX (14) | 26.52 | Buy |
| Williams %R (14) | -57.75 | Neutral |
| ATR (14) | 7.56 | High Volatility |
| ROC (12) | -12.78 | Sell |
| Stoch RSI (14) | 82.02 | Sell |
| UO (7,14,28) | 46.58 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 Feb - Suzlon identifies Key Managerial Personnel and disclosure contacts under Reg 30(5), dated 9 Feb 2026. | [Updation Of Information As per Regulation 30(5) Of The SEBI (LODR) Regulations, 2015. 9 Feb - Suzlon identifies Key Managerial Personnel and disclosure contacts under Reg 30(5), dated 9 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9f5c17a8-f158-43c9-bcde-dff53f05fe63.pdf) |
| 5h - Income-tax penalty Rs.1.02 Crore for FY2016-17 dropped; notified 17 Feb 2026. | [Updates On Penalty 5h - Income-tax penalty Rs.1.02 Crore for FY2016-17 dropped; notified 17 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/00986c9b-c963-456a-8f48-2d5020f116c1.pdf) |
| 5 Feb - Q3 FY26 conference call audio uploaded on 5 Feb 2026 to company website. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 5 Feb - Q3 FY26 conference call audio uploaded on 5 Feb 2026 to company website.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fbd7cb4c-304f-4ce4-9dd2-83a6c220ea13.pdf) |
| 3 July 2026 - Certificate for Structured Digital database for quarter ended on 31st March, 2026 | [Structural Digital Database 3 July 2026 - Certificate for Structured Digital database for quarter ended on 31st March, 2026](https://nsearchives.nseindia.com/corporate/AELAPRAMEYA_03072026114945_Certificate.pdf) |
| 3 Aug - AGM held on 1 Aug 2026; all resolutions, including FY26 financial adoption, passed. | [Shareholders meeting 3 Aug - AGM held on 1 Aug 2026; all resolutions, including FY26 financial adoption, passed.](https://nsearchives.nseindia.com/corporate/AELAPRAMEYA_03082026130011_letter_merged_searchable.pdf) |
| 28 May 2026 - FY26 press release: collections normalized, ₹100 crore receivables recovered, bids worth ₹190 crore submitted, subsidiary facility planned. | [Press Release 28 May 2026 - FY26 press release: collections normalized, ₹100 crore receivables recovered, bids worth ₹190 crore submitted, subsidiary facility planned.](https://nsearchives.nseindia.com/corporate/AELAPRAMEYA_28052026225215_press.pdf) |
| 28 May 2026 - Board approved audited FY26 results, auditor reports, related party transactions, and AGM scrutiniser appointment. | [Outcome of Board Meeting 28 May 2026 - Board approved audited FY26 results, auditor reports, related party transactions, and AGM scrutiniser appointment.](https://nsearchives.nseindia.com/corporate/AELAPRAMEYA_28052026205808_OUTCOME.pdf) |
| 28 May 2026 - Aprameya Medtech appoints Jalan Alkesh & Associates as secretarial auditor on 27 May 2026 for five years. | [General Updates 28 May 2026 - Aprameya Medtech appoints Jalan Alkesh & Associates as secretarial auditor on 27 May 2026 for five years.](https://nsearchives.nseindia.com/corporate/AELAPRAMEYA_28052026204450_MEDTECH.pdf) |
| 28 May 2026 - Aprameya Engineering Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | [Outcome of Board Meeting 28 May 2026 - Aprameya Engineering Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.](https://nsearchives.nseindia.com/corporate/AELAPRAMEYA_28052026174746_result.pdf) |
| 28 May 2026 - Aprameya Engineering Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | [Outcome of Board Meeting 28 May 2026 - Aprameya Engineering Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.](https://nsearchives.nseindia.com/corporate/AELAPRAMEYA_28052026175820_result.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_29651_APRAMEYA_2025_2026_A_23950982_08072026152718.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26793_APRAMEYA_2024_2025_A_08072025170033.pdf) |
| from nse | [Financial Year 2013 from nse](https://archives.nseindia.com/annual_reports/AR_1313_SUZLON_2012_2013_02092013094718.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b3f426be-6b96-4a2e-855b-2e4937080064.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bd2b3794-e202-4cba-9270-6d0b1115f539.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7738a1c9-43a3-46eb-a1b7-4e3efa4c0d02.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532667/75765532667.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532667/70072532667.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532667/65613532667.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532667/5326670319.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2016 | [Concall - Sep 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=EE56DECD_5930_4FAA_8EB1_732459F97059_180622.pdf) |
| Oct 2016 | [Concall - Oct 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=971F4B3C_9AB0_4EC5_B4B6_6AE9E763215A_142507.pdf) |
| Oct 2016 | [Concall - Oct 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02E3DA8E_7A90_4E59_8495_332D02005CF3_144538.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/AELAPRAMEYA_14112025153720_analyst.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/44870f4e-11a6-4e64-b668-e9643b633e87.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d2912150-1a8e-4d2e-9309-7d237875ee40.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1900fd3b-f25b-4a41-9f9a-b14754c8d74a.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/16918bdb-d73a-4cc0-91fe-17008be509aa.pdf) |
| Nov 2020 | [Concall - Nov 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d3e2aa6-2974-4854-bbd9-43de9be3eadd.pdf) |
| May 2025 | [Concall - May 2025](https://nsearchives.nseindia.com/corporate/AELAPRAMEYA_17052025170011_1.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:19:52.250Z.